Longeveron Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$0.70

-0.01 (-0.77%)

As of Jun 30, 4:36 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +3,831.0% upside

Low Target $21.92

Average Target $27.69

High Target $40.08

Current Price $0.70

Current
$0.70

Target
$27.69

$21.92 $27.69 avg $40.08

Scenario Analysis

Bear Case

$21.92

3,011.9%

Low target

Base Case

$27.69

+3,831.0%

Avg target

Bull Case

$40.08

+5,589.9%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$1.80

-60.9% from high

52-Week Low

$0.48

+48.3% from low

Target vs 52W High

$27.69

+1,438.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%